Literature DB >> 34073744

Prognostic Value of Echocardiographic Right Ventricular Function Parameters in the Presence of Severe Tricuspid Regurgitation.

Matthias Schneider1, Varius Dannenberg1, Andreas König1, Welf Geller1, Thomas Binder1, Christian Hengstenberg1, Georg Goliasch1.   

Abstract

BACKGROUND: Presence of severe tricuspid regurgitation (TR) has a significant impact on assessment of right ventricular function (RVF) in transthoracic echocardiography (TTE). High trans-valvular pendulous volume leads to backward-unloading of the right ventricle. Consequently, established cut-offs for normal systolic performance may overestimate true systolic RVF.
METHODS: A retrospective analysis was performed entailing all patients who underwent TTE at our institution between 1 January 2013 and 31 December 2016. Only patients with normal left ventricular systolic function and with no other valvular lesion were included. All recorded loops were re-read by one experienced examiner. Patients without severe TR (defined as vena contracta width ≥7 mm) were excluded. All-cause 2-year mortality was chosen as the end-point. The prognostic value of several RVF parameters was tested.
RESULTS: The final cohort consisted of 220 patients, 88/220 (40%) were male. Median age was 69 years (IQR 52-79), all-cause two-year mortality was 29%, median TAPSE was 19 mm (15-22) and median FAC was 42% (30-52). In multivariate analysis, TAPSE with the cutoff 17 mm and FAC with the cutoff 35% revealed non-significant hazard ratios (HR) of 0.75 (95%CI 0.396-1.421, p = 0.38) and 0.845 (95%CI 0.383-1.867, p = 0.68), respectively. TAPSE with the cutoff 19 mm and visual eyeballing significantly predicted survival with HRs of 0.512 (95%CI 0.296-0.886, p = 0.017) and 1.631 (95%CI 1.101-2.416, p = 0.015), respectively.
CONCLUSIONS: This large-scale all-comer study confirms that RVF is one of the main drivers of mortality in patients with severe isolated TR. However, the current cut-offs for established echocardiographic parameters did not predict survival. Further studies should investigate the prognostic value of higher thresholds for RVF parameters in these patients.

Entities:  

Keywords:  FAC; GLS; RVF; TAPSE; TR

Year:  2021        PMID: 34073744     DOI: 10.3390/jcm10112266

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  19 in total

1.  Does left ventricular shape influence clinical outcome in heart failure?

Authors:  K J Harjai; R Edupuganti; E Nunez; T Turgut; L Scott; N G Pandian
Journal:  Clin Cardiol       Date:  2000-11       Impact factor: 2.882

Review 2.  Secondary valve regurgitation in patients with heart failure with preserved ejection fraction, heart failure with mid-range ejection fraction, and heart failure with reduced ejection fraction.

Authors:  Philipp E Bartko; Martin Hülsmann; Judy Hung; Noemi Pavo; Robert A Levine; Philippe Pibarot; Alec Vahanian; Gregg W Stone; Georg Goliasch
Journal:  Eur Heart J       Date:  2020-08-01       Impact factor: 29.983

Review 3.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Roberto M Lang; Luigi P Badano; Victor Mor-Avi; Jonathan Afilalo; Anderson Armstrong; Laura Ernande; Frank A Flachskampf; Elyse Foster; Steven A Goldstein; Tatiana Kuznetsova; Patrizio Lancellotti; Denisa Muraru; Michael H Picard; Ernst R Rietzschel; Lawrence Rudski; Kirk T Spencer; Wendy Tsang; Jens-Uwe Voigt
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-03       Impact factor: 6.875

4.  New Directions in Right Ventricular Assessment Using 3-Dimensional Echocardiography.

Authors:  Karima Addetia; Denisa Muraru; Luigi P Badano; Roberto M Lang
Journal:  JAMA Cardiol       Date:  2019-09-01       Impact factor: 14.676

5.  Improvement in nutritional status - a determinant of successful transcatheter tricuspid valve repair?

Authors:  Matthias Schneider; Julia Mascherbauer
Journal:  Eur J Heart Fail       Date:  2020-03-25       Impact factor: 15.534

6.  Prognostic Implications of Right Ventricular Remodeling and Function in Patients With Significant Secondary Tricuspid Regurgitation.

Authors:  Marlieke F Dietz; Edgard A Prihadi; Pieter van der Bijl; Laurien Goedemans; Bart J A Mertens; Erhan Gursoy; Olton S van Genderen; Nina Ajmone Marsan; Victoria Delgado; Jeroen J Bax
Journal:  Circulation       Date:  2019-06-12       Impact factor: 29.690

7.  2017 ESC/EACTS Guidelines for the management of valvular heart disease.

Authors:  Helmut Baumgartner; Volkmar Falk; Jeroen J Bax; Michele De Bonis; Christian Hamm; Per Johan Holm; Bernard Iung; Patrizio Lancellotti; Emmanuel Lansac; Daniel Rodriguez Muñoz; Raphael Rosenhek; Johan Sjögren; Pilar Tornos Mas; Alec Vahanian; Thomas Walther; Olaf Wendler; Stephan Windecker; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2017-09-21       Impact factor: 29.983

8.  Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension.

Authors:  Stefano Ghio; Catherine Klersy; Giulia Magrini; Andrea Maria D'Armini; Laura Scelsi; Claudia Raineri; Michele Pasotti; Alessandra Serio; Carlo Campana; Mario Viganò
Journal:  Int J Cardiol       Date:  2008-12-12       Impact factor: 4.164

9.  Severe tricuspid regurgitation: prognostic role of right heart remodelling and pulmonary hypertension.

Authors:  Matthias Schneider; Andreas König; Welf Geller; Varius Dannenberg; Max-Paul Winter; Thomas Binder; Christian Hengstenberg; Julia Mascherbauer; Georg Goliasch
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-01-24       Impact factor: 6.875

Review 10.  Echocardiographic evaluation of the right heart.

Authors:  Matthias Schneider; Thomas Binder
Journal:  Wien Klin Wochenschr       Date:  2018-03-19       Impact factor: 1.704

View more
  1 in total

1.  Prognostic impact of functional mitral regurgitation prior to left ventricular assist device implantation.

Authors:  Jonas Pausch; Oliver Bhadra; Julian Mersmann; Lenard Conradi; Bjoern Sill; Markus J Barten; Hermann Reichenspurner; Alexander M Bernhardt
Journal:  J Cardiothorac Surg       Date:  2022-02-25       Impact factor: 1.637

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.